Stock Price
8.36
Daily Change
0.09 1.03%
Monthly
-23.21%
Yearly
-58.62%
Q2 Forecast
8.10

Adma Biologics reported $0.19 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2027Q1 Mar/2026 0.19 0.19 0.12 May/06




Eps Change Date
Adma Biologics USD 0.19 0.01 Mar/2026
Alnylam Pharmaceuticals USD 1.99 0.74 Mar/2026
BioCryst Pharmaceuticals USD 1.17 1.1 Dec/2025
Minerva Neurosciences USD -0.56 3.53 Dec/2024
Novavax USD 0.13 0.59 Dec/2025
Omeros USD -1.12 0.37 Jun/2024
Takeda JPY -15.56 81.3 Mar/2026